Skip to main content

KBC Group NV

Position in NVAX — Novavax Inc

CIK 1411133 Brussels, C9

Position in NVAX

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$44,707
+$6,075 QoQ
Shares Held
4,746
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#174
of 263 holders
Holding Since
Jun 2021
16 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NVAX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

KBC Group NV holds $308,329,117 across 107 Biotechnology names. NVAX ranks #96 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVAX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $44,707 4,746
2026-03-31 $38,632 4,746
2025-12-31 $23,634 3,517
2025-09-30 $30,492 3,517
2025-06-30 $22,157 3,517
2025-03-31 $50,985 7,954
2024-12-31 $63,950 7,954
2024-09-30 $50,987 4,037
2024-06-30 $51,108 4,037
2023-09-30 $13,017 1,798
2022-09-30 $13,395 736
2022-06-30 $37,852 736
2022-03-31 $239,804 3,256
2021-12-31 $465,835 3,256
2021-09-30 $1,180,008 5,692
2021-06-30 $1,208,468 5,692